• 1
    Pocock SJ. Clinical Trials: a Practical Approach. New York: Wiley, 1996.
  • 2
    Sibbald B, Roland M. Understanding controlled trials: Why are randomised controlled trials important? BMJ 1998; 316: 201.
  • 3
    Schulz K. Assessing allocation concealment and blinding in randomised controlled trials: why bother? Evid Based Nurs 2001; 4: 46.
  • 4
    Gilbert J, Rosenberg P. There’s no such thing as a free drug. Wall St J, 2004. (accessed January 2008).
  • 5
    About NICE. (accessed January 2008).
  • 6
    Khan KS, Popay J, Kleijnen J. Development of a review protocol. In: KhanKS, Ter RietG, GlanvilleJ, SowdenAJ and KleijnenJ (eds), Undertaking Systematic Reviews of Research on Effectiveness. CRD Report Number 4, 2nd edn. York: Centre for Reviews and Dissemination, 2001, pp. 18.
  • 7
    Pilkington K, Boshnakova A, Clarke M et al. ‘No language restrictions’ in database searches: what does this really mean? J Altern Complement Med 2005; 11: 2057.
  • 8
    Bravo VY, Dunn G, Asseburg C et al. A simultaneous comparison of multiple pharmacological treatments for bipolar disorder. Abstract presented at the XIV Cochrane Colloquium, 23–26 October 2006, Dublin, Ireland.
  • 9
    Juni P, Stettler C, Shang A et al. Exploring and summarising networks of rials comparing multiple interventions. Abstract presented at the XIV Cochrane Colloquium, 23–26 October 2006, Dublin, Ireland.
  • 10
    Shrier I, Steele R, Platt R. A novel approach to mixed treatment meta-analysis. Abstract presented at the XIV Cochrane Colloquium, 23–26 October 2006, Dublin, Ireland.
  • 11
    Song F, Harvey I, Lilford R. Discrepancy between direct comparison and adjusted indirect comparison of new versus conventional pharmaceutical interventions. Abstract presented at the XIV Cochrane Colloquium, 23–26 October 2006, Dublin, Ireland.
  • 12
    Merlin T, Mundy L, Hiller J. Caught between a rock and a hard place: indirect comparisons and the trade-off between information and methodological rigour. Abstract presented at the 1st Annual Health Technology Assessment International, 30 May – 2 June 2004, Krakow, Poland.
  • 13
    Pignon J-P, Arriagada R, Ihde DC et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. New Engl J Med 1992; 327: 161824.
  • 14
    Gøtzsche PC. Meta-analysis of NSAIDs: contribution of drugs, doses, trial designs, and meta-analytic techniques. Scand J Rheumatol 1993; 22: 25560.
  • 15
    Arriagada R, Pignon JP, Ihde DC et al. Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patients. Anticancer Res 1994; 14: 3336.
  • 16
    Lowenthal A, Buyse M. Secondary prevention of stroke: does dipyridamole add to aspirin. Acta Neurol Belg 1994; 94: 2434.
  • 17
    Matchar DB, McCrory D, Barnett HJM et al. Medical treatments for stroke prevention. Ann Intern Med 1994; 121: 4153.
  • 18
    Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995; 15: 81944.
  • 19
    Lefering R, Neugebauer EAM. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995; 23: 1294303.
  • 20
    Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899909.
  • 21
    Piccinelli M, Pini S, Bellantuono C et al. Efficacy of drug treatment in obsessive-compulsive disorder: a meta-analytic review. Brit J Psych 1995; 166: 42443.
  • 22
    Poynard T, Lemaire M, Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol 1995; 7: 6615.
  • 23
    Rossouw JE. Lipid-lowering interventions in angiographic trials. Am J Cardiol 1995; 76: 86C92C.
  • 24
    Tramèr M, Moore A, McQuay H. Prevention of vomiting after paediatric strabismus surgery: a systematic review using the numbers-needed-to-treat method. Br J Anaesth 1995; 75: 55661.
  • 25
    Boersma E, Maas ACP, Deckers JW et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 7715.
  • 26
    Koch M, Dezi A, Ferrario F et al. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. Arch Intern Med 1996; 156: 232132.
  • 27
    Leizorovicz A. Comparison of the efficacy and safety of low molecular weight heparin in the initial treatment of deep vein thrombosis: an updated meta-analysis. Drugs 1996; 52 (Suppl. 7): 307.
  • 28
    Poynard T, Leroy V, Cohard M et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and titration. Hepatology 1996; 24: 7789.
  • 29
    Zalcberg JR, Siderov J, Simes J. The role of 5-flurouracil dose in the adjuvant therapy of colorectal cancer. Ann Oncol 1996; 7: 416.
  • 30
    Zhang WY, Po ALW. Analgesic efficacy of paracetamol and its combination with codeine and caffeine in surgical pain – a meta-analysis. J Clin Pharm Ther 1996; 21: 26182.
  • 31
    Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997; 50: 68391.
  • 32
    Po ALW, Zhang WY. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol. BMJ 1997; 315: 156571.
  • 33
    Moore RA, McQuay HJ. Single patient data meta-analysis of 3,453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain 1997; 69: 28794.
  • 34
    Moore A, Collins S, Carroll D, McQuay H. Paracetamol with and without codeine in acute pain: a quantitative systematic review. Pain 1997; 70: 193201.
  • 35
    Srisurapanont M, Maneeton N. Comparison of the efficacy and acceptability of atypical antipsychotic drugs: a meta-analysis of randomized, placebo-controlled trials. J Med Assoc Thailand 1999; 82: 3416.
  • 36
    Einarson TR, Kulin NA, Tingey D et al. Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma. Clin Ther 2000; 22: 150215.
  • 37
    Van Der Heijden JF, Prins MH, Büller HR. For the initial treatment of venous thromboembolism: are all low-molecular-weight heparin compounds the same? Thrombosis Res 2000; 100: 12130.
  • 38
    Horn J, Limburg M. Calcium antagonists for acute ischemic stroke. Cochrane Database Sys Rev 2000, Issue 1. Art. No.: CD001928.
  • 39
    Song F, Glenny A-M, Altman DG. Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery. Cont Clin Trials 2000; 21: 48897.
  • 40
    Otto MW, Tuby KS, Gould RA et al. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psych 2001; 158: 198992.
  • 41
    Sauriol L, Laporta M, Edwardes MD et al. Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach. Clin Ther 2001; 23: 94256.
  • 42
    Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 7186.
  • 43
    Ferrari MD, Goadsby PJ, Roon KI et al. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002; 22: 63358.
  • 44
    Coomarasamy A, Knox EM, Gee H et al. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials. Br J Obstet Gynaecol 2003; 110: 10459.
  • 45
    Hind D, Calvert N, McWilliams R et al. Ultrasonic devices for central venous cannulation: meta-analysis. BMJ 2003; 327: 3617.
  • 46
    Hochberg MC, Tracy JK, Hawkins-Holt M et al. Comparison of the efficacy of the tumour necrosis factor α blocking agent adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis 2003; 62 (Suppl. II): ii136.
  • 47
    Lim E, Ali Z, Ali A et al. Indirect comparison meta-analysis of aspirin therapy after coronary surgery. BMJ 2003; 327: 130913.
  • 48
    Psaty BM, Lumley T, Furberg CD et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 253444.
  • 49
    Rice VH, Stead LF. Nursing interventions for smoking cessation. Cochrane Database Sys Rev 2008, Issue 1. Art. No.: CD001188.
  • 50
    Wehren LE, Hosking D, Hochberg MC. Putting evidence-based medicine into clinical practice: comparing anti-resolve agents for the treatment of osteoporosis. Curr Med Res Opin 2004; 20: 52531.
  • 51
    Ballesteros J. Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine inhibitors by using general linear models. J Clin Psychopharmocol 2005; 25: 12731.
  • 52
    Berner MM, Kriston L, Harms A. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations. Intern J Impotence Res 2005; 18: 22935.
  • 53
    Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005; 331: 897900.
  • 54
    Dodwell D, Vergote I. A comparison of fluvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer. Cancer Treat Rev 2005; 31: 27482.
  • 55
    Mandema JW, Cox E, Alderman J. Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain – results of a model-based meta-analysis that accounts for encapsulation. Cephalagia 2005; 25: 71525.
  • 56
    Otoul C, Arrigo C, Van Rijckevorsel K et al. Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy. Clin Neuropharmacol 2005; 28: 728.
  • 57
    Richy F, Schacht E, Bruyere O et al. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Calcified Tissue Intern 2005; 76: 17686.
  • 58
    Abou-Setta A. Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons. Reprod BioMed Online 2006; 12: 1918.
  • 59
    Chou R, Fu R, Huffman LH, Korthuis PT. Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses. Lancet 2006; 368: 150315.
  • 60
    Cooper NJ, Sutton AJ, Lu G et al. Mixed comparison of stroke prevention treatments in individual with nonrheumatic atrial fibrillation. Arch Intern Med 2006; 166: 126975.
  • 61
    Davies L, Brown TJ, Haynes S et al. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 2006; 10: 1210.
  • 62
    Eckert L, Lançon C. Duloxetine compared with fluoxetine and venalfaxine: use of meta-regression analysis for indirect comparisons. BMC Psych 2006; 6: 30.
  • 63
    Gartlehner G, Hansen RA, Jonas BL et al. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 2006; 33: 2398408.
  • 64
    Jensen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006; 22: 67181.
  • 65
    Kyrgiou M, Salanti G, Pavlidis N et al. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. J Nat Cancer Inst 2006; 98: 165563.
  • 66
    Lip GYH, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thrombosis Res 2006; 118: 32133.
  • 67
    Purkayastha S, Athanasiou T, Tekkis PP et al. Magnetic resonance colonography vs computed tomography colonography for the diagnosis of colorectal cancer: an indirect comparison. Colorectal Dis 2006; 9: 10011.
  • 68
    Small LN, Lau J, Snydman DR. Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic preemptive therapies. Clin Infect Dis 2006; 43: 86980.
  • 69
    Stettler C, Allemann S, Egger M et al. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart 2006; 92: 6507.
  • 70
    Zhou Z, Rahme E, Pilote L. Are statins created equal? Evidence from randomized trials of pravatsatin, simvastatin, and atorvastatin for cardiovascular disease prevention Am Heart J 2006; 151: 27381.
  • 71
    Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369: 2017.
  • 72
    Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thrombosis Res 2007; 119: 26574.
  • 73
    Nixon RM, Bansback N, Brennan A. Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. Stat Med 2007; 26: 123754.
  • 74
    Yazdanpanah Y, Sissoko D, Egger M et al. Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials. BMJ 2007; 328: 24955.
  • 75
    Bland M, Peacock J. Interpreting statistics with confidence. Obstet Gynaecol 2002; 4: 17680.
  • 76
    Greenhalgh T. How to read a paper: Statistics for the non-statistician I: different types of data need different statistical tests. BMJ 1997; 315: 3646.
  • 77
    Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005; 5: 21827.
  • 78
    Jung C, Engelmann E, Borner K, Offermann G. Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation. Transplant Proc 2001; 33: 36213.
  • 79
    Hasselblad V, Kong DF. Statistical methods for comparison to placebo in active-control trials. Drug Inform J 2001; 35: 43549.
  • 80
    Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003; 326: 210.
  • 81
    Song F, Glenny AM, Altman DG. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003; 326: 4726.
  • 82
    Glenny AM, Altman DG, Song F et al. Indirect comparisons of competing interventions. Health Technol Assess 2005; 9: 1148.
  • 83
    Eddy DM, Hasselblad V, Shachter R. A Bayesian method for synthesizing evidence – the Confidence Profile Method. Intern J Technol Assess Health Care 1990; 6: 3155.
  • 84
    Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester: Wiley, 2007.
  • 85
    Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21: 231324.
  • 86
    Ades AE. A chain of evidence with mixed comparisons: models for multiparameter synthesis and consistency of evidence. Stat Med 2003; 22: 29953016.
  • 87
    Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23: 310524.
  • 88
    WinBUGS with DoodleBUGS. Imperial College and the Medical Research Council, 2007. (accessed January 2008).
  • 89
    Abrams K. Interpreting tau: OR Scale. Presented at the Indirect and Mixed Treatment Comparisons Course, 19–21 September 2007, University of Leicester, UK.
  • 90
    Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med 1997; 16: 274158.
  • 91
    Higgins JP, Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat Med 1996; 15: 273349.